Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Cancer Investigation|August 29, 2002
Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancerElizabeth A Johnson, David S Klimstra, James E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancerS L Graziano, R Mazid, N Newman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancerS L Graziano, G P Gamble, N B Newman, et al.
Cancer Medicine|June 24, 2022
Genomic landscape of non-small-cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiencyPrashanth Ashok Kumar, Stephen L Graziano, Natalie Danziger, et al.
Journal of the American College of Cardiology|June 1, 1993
Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiographyN R Powe, A J Davidoff, R D Moore, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010
Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633Stephen L Graziano, Lin Gu, Xiaofei Wang, et al.
Cancer Research|May 1, 1987
Quantitative assay of human T-cell leukemia/lymphoma virus transformationS L Graziano, B M Lehr, S A Merl, et al.
Pageof 8